These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37670813)

  • 1. IFN-γ: A Crucial Player in the Fight Against HBV Infection?
    Hillaire MLB; Lawrence P; Lagrange B
    Immune Netw; 2023 Aug; 23(4):e30. PubMed ID: 37670813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
    Chen J; Xu W; Chen Y; Xie X; Zhang Y; Ma C; Yang Q; Han Y; Zhu C; Xiong Y; Wu K; Liu F; Liu Y; Wu J
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study.
    Ma H; Lim TH; Leerapun A; Weltman M; Jia J; Lim YS; Tangkijvanich P; Sukeepaisarnjaroen W; Ji Y; Le Bert N; Li D; Zhang Y; Hamatake R; Tan N; Li C; Strasser SI; Ding H; Yoon JH; Stace NH; Ahmed T; Anderson DE; Yan L; Bertoletti A; Zhu Q; Yuen MF
    JHEP Rep; 2021 Dec; 3(6):100361. PubMed ID: 34661089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
    Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
    J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on hepatitis B virus infection.
    You CR; Lee SW; Jang JW; Yoon SK
    World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
    Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP
    J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
    Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
    Front Immunol; 2021; 12():745802. PubMed ID: 34671360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse facets of MDSC in different phases of chronic HBV infection: Impact on HBV-specific T-cell response and homing.
    Pal S; Dey D; Chakraborty BC; Nandi M; Khatun M; Banerjee S; Santra A; Ghosh R; Ahammed SM; Chowdhury A; Datta S
    Hepatology; 2022 Sep; 76(3):759-774. PubMed ID: 35000202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
    Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
    BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells.
    Mao R; Zhang J; Jiang D; Cai D; Levy JM; Cuconati A; Block TM; Guo JT; Guo H
    J Virol; 2011 Jan; 85(2):1048-57. PubMed ID: 21084489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice.
    Di Scala M; Otano I; Gil-Fariña I; Vanrell L; Hommel M; Olagüe C; Vales A; Galarraga M; Guembe L; Ortiz de Solorzano C; Ghosh I; Maini MK; Prieto J; González-Aseguinolaza G
    J Virol; 2016 Oct; 90(19):8563-74. PubMed ID: 27440883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.
    Jegaskanda S; Ahn SH; Skinner N; Thompson AJ; Ngyuen T; Holmes J; De Rose R; Navis M; Winnall WR; Kramski M; Bernardi G; Bayliss J; Colledge D; Sozzi V; Visvanathan K; Locarnini SA; Kent SJ; Revill PA
    J Virol; 2014 Sep; 88(18):10412-20. PubMed ID: 24872585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways.
    Liu Y; Li J; Chen J; Li Y; Wang W; Du X; Song W; Zhang W; Lin L; Yuan Z
    J Virol; 2015 Feb; 89(4):2287-300. PubMed ID: 25505063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
    Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
    J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.
    Alfaiate D; Lucifora J; Abeywickrama-Samarakoon N; Michelet M; Testoni B; Cortay JC; Sureau C; Zoulim F; Dény P; Durantel D
    Antiviral Res; 2016 Dec; 136():19-31. PubMed ID: 27771387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of CD69 levels on TCR Vα7.2
    Yong YK; Tan HY; Saeidi A; Rosmawati M; Atiya N; Ansari AW; Rajarajeswaran J; Vadivelu J; Velu V; Larsson M; Shankar EM
    Innate Immun; 2017 Jul; 23(5):459-467. PubMed ID: 28606013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.